These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12059996)

  • 1. Economic evaluation of epilepsy treatment: a review of the literature.
    Heaney DC; Begley CE
    Epilepsia; 2002; 43 Suppl 4():10-6. PubMed ID: 12059996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of epilepsy therapy: how should treatment effects be measured?
    Langfitt J; Wiebe S
    Epilepsia; 2002; 43 Suppl 4():17-24. PubMed ID: 12059997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of surgical and medical costs for refractory epilepsy.
    Platt M; Sperling MR
    Epilepsia; 2002; 43 Suppl 4():25-31. PubMed ID: 12059998
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic analysis of epilepsy care.
    Beran RG
    Epilepsia; 1999; 40 Suppl 8():19-24. PubMed ID: 10563591
    [No Abstract]   [Full Text] [Related]  

  • 5. Economics in epilepsy treatment choices: our certain fate?
    Heaney DC; Beran RG; Halpern MT
    Epilepsia; 2002; 43 Suppl 4():32-8. PubMed ID: 12059999
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):309-15. PubMed ID: 20545595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
    Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
    Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of the new antiepileptic drugs.
    Heaney D
    Epilepsia; 1999; 40 Suppl 8():25-31. PubMed ID: 10563592
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic burden of epilepsy in India.
    Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B
    Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of antiepileptic drug therapy: a methodologic review.
    Levy P
    Epilepsia; 2002 May; 43(5):550-8. PubMed ID: 12027918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two methods for estimating the health care costs of epilepsy.
    Frost FJ; Hurley JS; Petersen HV; Gunter MJ; Gause D
    Epilepsia; 2000 Aug; 41(8):1020-6. PubMed ID: 10961630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of childhood epilepsy in Italy: comparative findings from three health care settings.
    Guerrini R; Battini R; Ferrari AR; Veggiotti P; Besana D; Gobbi G; Pezzani M; Berta E; Tetto A; Beghi E; Monticelli ML; Tediosi F; Garattini L; Russo S; Rasmini P; Amadi A; Quarti P; Fabrizzi R;
    Epilepsia; 2001 May; 42(5):641-6. PubMed ID: 11380572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
    Noda AH; Hermsen A; Berkenfeld R; Dennig D; Endrass G; Kaltofen J; Safavi A; Wiehler S; Carl G; Meier U; Elger CE; Menzler K; Knake S; Rosenow F; Strzelczyk A
    Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the costs of managing childhood epilepsy.
    Beghi E; Frigeni B; Beghi M; De Compadri P; Garattini L
    Pharmacoeconomics; 2005; 23(1):27-45. PubMed ID: 15693726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World-wide disparities in epilepsy care: a Latin American outlook.
    Fandiño-Franky J; Silfvenius H
    Epilepsia; 1999; 40 Suppl 8():48-54. PubMed ID: 10563596
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study.
    Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A
    Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.